Beneficial effects of aminoguanidine on skin flap survival in diabetic rats
- PMID: 23304118
- PMCID: PMC3532918
- DOI: 10.1155/2012/721256
Beneficial effects of aminoguanidine on skin flap survival in diabetic rats
Abstract
Random flaps in DM patients have poor reliability for wound coverage, and flap loss remains a complex challenge. The protective effects of aminoguanidine (AG) administration on the survival of dorsal random flaps and oxidative stress were studied in diabetic rats. Two months after the onset of DM, dorsal McFarlane flaps were raised. Forty rats were divided into four groups: (1) control, (2) AG, (3) DM, and (4) DM + AG groups. Flap viability, determined with the planimetric method, and free-radical measurements were investigated. In addition, HbA1c and blood glucose levels, body weight measurements, and histopathological examinations were evaluated. The mean flap necrotic areas (%) in Groups I to IV were 50.9 ± 13.0, 32.9 ± 12.5, 65.2 ± 11.5, and 43.5 ± 14.7, respectively. The malondialdehyde (MDA) and nitric oxide (NO) levels were higher in the DM group than in the nondiabetic group, while the reduced glutathione (GSH) levels and superoxide dismutase (SOD) activity were reduced as a result of flap injury. In the diabetic and nondiabetic groups, AG administration significantly reduced the MDA and NO levels and significantly increased GSH content and SOD enzyme activity. We concluded that AG plays an important role in preventing random pattern flap necrosis.
Figures
References
-
- Kennedy L, Baynes JW. Non-enzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia. 1984;26(2):93–98. - PubMed
-
- Vlassara H, Palace MR. Glycoxidation: the menace of diabetes and aging. Mount Sinai Journal of Medicine. 2003;70(4):232–241. - PubMed
-
- Sun F, Iwaguchi K, Shudo R, et al. Change in tissue concentrations of lipid hydroperoxides, vitamin C and vitamin E in rats with streptozotocin-induced diabetes. Clinical Science. 1999;96(2):185–190. - PubMed
-
- Thornalley PJ. Use of aminoguanidine (Pimagedine) to prevent the formation of advanced glycation endproducts. Archives of Biochemistry and Biophysics. 2003;419(1):31–40. - PubMed
-
- Katz A, Ekberg K, Johansson BL, Wahren J. Diminished skin blood flow in type I diabetes: evidence for non-endothelium-dependent dysfunction. Clinical Science. 2001;101(1):59–64. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical